LEGN
Legend Biotech

1,035
Mkt Cap
$3.53B
Volume
953.00
52W High
$45.30
52W Low
$16.24
PE Ratio
-14.66
LEGN Fundamentals
Price
$19.56
Prev Close
$19.14
Open
$19.21
50D MA
$19.66
Beta
0.50
Avg. Volume
2.41M
EPS (Annual)
-$0.9686
P/B
3.50
Rev/Employee
$240,534.92
$5,177.83
Loading...
Loading...
Poll

Earnings Recap

• Reported GAAP EPS of -$0.16 down -214.29% YoY • Reported revenue of $306.3M up 64.24% YoY • Legend Biotech expects to achieve a company-wide operating profit beyond 2026, supported by its strong balance sheet with $949 million in cash and cash equivalents as of December 31, 2025.

Bullish

Legend Biotech achieved CARVYKTI franchise profitability for FY 2025, treating over 10,000 patients and expanding globally. The company also advanced its pipeline with new candidates and strengthened R&D capabilities.

Bearish

Legend Biotech reported a Q4 2025 net loss of $30.9M, largely due to foreign currency losses, alongside increased selling and administrative expenses. The company also faces patent protection challenges.

Latest LEGN News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.